JPMorgan Funds - Korea Equity Fund X (acc) - USDRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 37.6 | 8.9 | -19.5 | 10.1 | 0.2 | |
+/-Cat | 3.4 | 12.4 | 1.4 | -3.2 | 2.0 | |
+/-B’mrk | -3.3 | 15.2 | -0.3 | -6.6 | 2.5 | |
Category: Korea Equity | ||||||
Category Benchmark: Morningstar Korea TME NR USD |
Key Stats | ||
NAV 28/03/2024 | USD 216.31 | |
Day Change | -0.31% | |
Morningstar Category™ | Korea Equity | |
ISIN | LU0301639828 | |
Fund Size (Mil) 28/03/2024 | USD 1113.13 | |
Share Class Size (Mil) 28/03/2024 | USD 1.05 | |
Max Initial Charge | - | |
Ongoing Charge 06/12/2023 | 0.16% |
Investment Objective: JPMorgan Funds - Korea Equity Fund X (acc) - USD |
To provide long-term capital growth by investing primarily in a concentrated portfolio of Korean companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
John Cho 13/06/2011 | ||
Ayaz Ebrahim 03/07/2017 | ||
Inception Date 18/06/2008 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
KOSPI TR KRW | Morningstar Korea TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPMorgan Funds - Korea Equity Fund X (acc) - USD | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
SK Hynix Inc | Technology | 9.66 |
Samsung Electronics Co Ltd | Technology | 8.63 |
LG Chem Ltd | Basic Materials | 4.30 |
Samsung BioLogics Co Ltd | Healthcare | 3.70 |
Hana Financial Group Inc | Financial Services | 3.21 |
Increase Decrease New since last portfolio | ||
JPMorgan Funds - Korea Equity Fund X (acc) - USD |